NCR3 and neoplasm: The myeloid K562 cells used in the expansion protocol may partially reflect the physiological interaction of NK cells and myeloid cells, which is particularly relevant in the tumor microenvironment36,37, providing signals like cytokines and ligands, e.g., the NKp30 ligand for NK cell activation38–40.